Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain.
Sanchez-Gonzalez B, Peñalver FJ, Medina A, Guillén H, Calleja M, Gironella M, Arranz R, Sebastian E, de Oña R, Cánovas A, de la Fuente I, Grande C, Sancho JM, Perez R, Domingo E, Lopez-Lorenzo JL, Prieto E, Panizo C, Gorosquieta A, Perez I, Cervera JM, Marin M, Mencha C, Ramila E, Salar A. Sanchez-Gonzalez B, et al. Among authors: guillen h. Leuk Res. 2012 Jun;36(6):709-14. doi: 10.1016/j.leukres.2011.10.024. Epub 2011 Dec 7. Leuk Res. 2012. PMID: 22154023
Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.
Alvarez-Larrán A, Pereira A, Cervantes F, Arellano-Rodrigo E, Hernández-Boluda JC, Ferrer-Marín F, Angona A, Gómez M, Muiña B, Guillén H, Teruel A, Bellosillo B, Burgaleta C, Vicente V, Besses C. Alvarez-Larrán A, et al. Among authors: guillen h. Blood. 2012 Feb 9;119(6):1363-9. doi: 10.1182/blood-2011-10-387787. Epub 2011 Dec 12. Blood. 2012. PMID: 22160617 Free article.
Two-weekly dose-adjusted (DA)-EPOCH-like chemotherapy with high-dose dexamethasone plus rituximab (DA-EDOCH14-R) in poor-prognostic untreated diffuse large B-cell lymphoma.
García-Suárez J, Flores E, Callejas M, Arribas I, Gil-Fernández JJ, Olmedilla G, Curto N, Guillén H, Casco CR, Martín Y, Burgaleta C. García-Suárez J, et al. Among authors: guillen h. Br J Haematol. 2013 Feb;160(4):510-4. doi: 10.1111/bjh.12144. Epub 2012 Dec 11. Br J Haematol. 2013. PMID: 23228045 Free article. Clinical Trial.
Alternative molecular and genomic strategies to provide a rapid response to alerts concerning the introduction of new emerging SARS-CoV-2 variants: the Omicron alert.
Herranz M, Buenestado-Serrano S, Martín-Escolano J, Molero-Salinas A, Alonso R, Catalán P, Muñoz P, García de Viedma D, Pérez-Lago L; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Herranz M, et al. Microbiol Spectr. 2023 Sep 22;11(5):e0107523. doi: 10.1128/spectrum.01075-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37737624 Free PMC article.
Systematic genomic analysis of SARS-CoV-2 co-infections throughout the pandemic and segregation of the strains involved.
Peñas-Utrilla D, Pérez-Lago L, Molero-Salinas A, Estévez A, Sanz A, Herranz M, Martínez-Laperche C, Andrés-Zayas C, Veintimilla C, Catalán P, Alonso R, Muñoz P, García de Viedma D; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Peñas-Utrilla D, et al. Genome Med. 2023 Jul 24;15(1):57. doi: 10.1186/s13073-023-01198-z. Genome Med. 2023. PMID: 37488638 Free PMC article.
A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic.
Peñas-Utrilla D, Sanz A, Catalán P, Veintimilla C, Alcalá L, Alonso R, Muñoz P, Pérez-Lago L, García de Viedma D; Gregorio Marañón Microbiology-ID COVID 19 Study Group. Peñas-Utrilla D, et al. BMC Microbiol. 2023 Jul 17;23(1):190. doi: 10.1186/s12866-023-02924-8. BMC Microbiol. 2023. PMID: 37460980 Free PMC article.
35 results